Cancer :: Health Canada approves Sativex for cancer pain

GW Pharmaceuticals plc (AIM: GWP) and Bayer Inc., a subsidiary of Bayer AG, announce that Health Canada has approved Sativex?, a cannabis derived pharmaceutical treatment, as adjunctive analgesic treatment in adult patients with advanced cancer who experience moderate to severe pain during the highest tolerated dose of strong opioid therapy for persistent background pain.

Glaucoma :: Alzheimer’s disease treatments may help treat major eye disease glaucoma

UK scientists have shown for the first time that key proteins involved in Alzheimer’s disease are also implicated in glaucoma, the major cause of irreversible blindness worldwide. Research carried out at the UCL Institute of Ophthalmology and funded by the Wellcome Trust has also shown that novel drugs being trialled for Alzheimer’s disease which target this protein may be used to treat glaucoma.

Skin :: Dermatologists can help consumers sort through the cosmeceutical clutter

When it comes to selecting a cosmeceutical to protect the skin from sun damage and the effects of aging, many consumers make their choices based on advertising campaigns. Combining cosmetic and pharmaceutical ingredients, cosmeceuticals on the market can overwhelm consumers. Presented with so many choices, consumers may wonder how to tell if a product works. According to dermatologists, cosmeceuticals with sunscreen are the ones that have you covered.

Aspirin :: Coated aspirin can still harm stomach

Some people take aspirin without ever having a problem with their stomach. Others develop low-grade stomach pain or get an ulcer. A few develop gastrointestinal bleeding severe enough to require a transfusion. But coated or buffered aspirin doesn?t do much to help, according to a four-page special report on aspirin in the August 2007 issue of the Harvard Heart Letter.

Vaccine :: Glaxo receives new HHS order for H5N1 bulk vaccine for USA

GlaxoSmithKline (NYSE:GSK), one of the world?s largest vaccine manufacturers, announced that US health agency HHS has placed another order to purchase bulk H5N1 antigen for the US national stockpile of pre-pandemic vaccines. The company also announced the start of the first North American pre-pandemic vaccine trials in the company?s global pre-pandemic influenza program.

Asthma :: ESRF lightsource helps tailoring new treatments against asthma

Asthma affects 300 million people worldwide and, according to World Health Organization, it killed 255 000 people in 2005. Asthma attacks are caused by an acute inflammatory reaction in the airways, a reaction that is largely due to actions of LTC4 synthase (an enzyme which catalyzes a synthesis process). For this reason asthma medicines often aim to block the downstream effects of LTC4 synthase.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack